Rebates are the dirty little secret of drug dispensing, and there are claims of how the providers providing a return of the “investment” are simply hiking prices to cover the cost of the rebate.  While the administration is hearing all this, and even heeding their cries, they have also taken the first step toward eliminating a “safe harbor” provision that allows rebates to be paid to the Medicare Part D without violating federal anti kickback laws.  So companies can do it, but the government can’t…so who knows who is protecting whom?